US Patent Issued to The Feinstein Institutes for Medical Research on June 9 for "Methods for reducing bleeding in hemophilia by vagus nerve stimulation to prime platelets" (New York, Connecticut Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,059, issued on June 9, was assigned to The Feinstein Institutes for Medical Research (Manhasset, N.Y.).

"Methods for reducing bleeding in hemophilia by vagus nerve stimulation to prime platelets" was invented by Jared M. Huston (Old Field, N.Y.) and Kevin J. Tracey (Old Greenwich, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of accelerating clot formation and increasing clot deposition in a hemophiliac subject. A vagal nerve stimulator (VNS) may be implanted in a hemophiliac subject. The hemophiliac subject may have developed antibodies to factor VIII and not been administered a clotting factor within the last 48 hours. The vagus nerv...